Alterations of Neocortical Pyramidal Cell Phenotype in the Ts65Dn Mouse Model of Down Syndrome: Effects of Environmental Enrichment

By Dierssen M.  

Cerebral Cortex, Vol. 13, Iss. 7, 2003-07 ,pp. : 758-764

Oxford University Press

Access to resources Recommend Favorite

Does ceruloplasmin differential express in the brain of Ts65Dn: a mouse mode of Down syndrome?

By Yu Bin   Kong Jing   Xing Baoling   Zhu Ziqiang   Zhang Bin   Wang Qiu-wei   Shao Shi-he  

Neurological Sciences, Vol. 35, Iss. 4, 2014-04 ,pp. : 589-593

Springer Publishing Company

Access to resources Recommend Favorite

Neonatal mice of the down syndrome model, Ts65Dn, exhibit upregulated VIP measures and reduced responsiveness of cortical astrocytes to VIP stimulation

By Sahir Nadia   Brenneman Douglas   Hill Joanna  

Journal of Molecular Neuroscience, Vol. 30, Iss. 3, 2006-10 ,pp. : 329-340

Humana Press, Inc

Access to resources Recommend Favorite

Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 13, Iss. 1, 2016-01 ,pp. : 97-106

Bentham Science Publishers

Access to resources Recommend Favorite

Loss of Cholinergic Phenotype in Basal Forebrain Coincides with Cognitive Decline in a Mouse Model of Down's Syndrome

By Granholm A-C.E.   Sanders L.A.   Crnic L.S.  

Experimental Neurology, Vol. 161, Iss. 2, 2000-02 ,pp. : 647-663

Academic Press

Access to resources Recommend Favorite